Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)-Reference-Cited by-同舟云学术

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)

Published:2017-08-01 Issue:8 Volume:12 Page:e0180651
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Messina Silvia,Solaro Claudio,Righini Isabella,Bergamaschi Roberto,Bonavita Simona,Bossio Roberto Bruno,Brescia Morra Vincenzo,Costantino Gianfranco,Cavalla Paola,Centonze Diego,Comi Giancarlo,Cottone Salvatore,Danni Maura Chiara,Francia Ada,Gajofatto Alberto,Gasperini Claudio,Zaffaroni Mauro,Petrucci Loredana,Signoriello Elisabetta,Maniscalco Giorgia Teresa,Spinicci Gabriella,Matta Manuela,Mirabella Massimiliano,Pedà Graziella,Castelli Letizia,Rovaris Marco,Sessa Edoardo,Spitaleri Daniele,Paolicelli Damiano,Granata Alfredo,Zappia Mario,Patti Francesco^ORCID,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference20 articles.

1. Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in Spain: the '5E' study;R Arroyo;Expert Rev Pharmacoecon Outcomes Res,2011

2. Symptoms, prevalence and impact of multiple sclerosis in younger patients: a multinational survey;F Patti;Neuroepidemiology,2014

3. Overview of MS spasticity;C Pozzilli;European neurology,2014

4. Treatments for spasticity and pain in multiple sclerosis: a systematic review;S Beard;Health technology assessment,2003

5. Anti-spasticity agents for multiple sclerosis;DT Shakespeare;The Cochrane database of systematic reviews,2003

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Therapeutic Potential and Molecular Mechanisms Underlying the Neuroprotective Effects of Sativex^® - A Cannabis-derived Spray;Mini-Reviews in Medicinal Chemistry;2024-08

2. Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical trial;Frontiers in Neurology;2024-07-24

3. Overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: a scoping review using a systematic approach;BMJ Open;2024-07

4. Trends in prescription and cost of Sativex, a cannabinoid-based medicine, in treating patients with multiple sclerosis in England;Journal of Pharmaceutical Policy and Practice;2024-05-08

5. Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders;Basic & Clinical Pharmacology & Toxicology;2024-03-13